Henry Schein (NSDQ:HSIC) said today it inked a deal with Cerebral Assessment Systems to distribute its Cognivue cognitive assessment screening device designed to detect early signs of dementia. Melville, N.Y.-based Henry Schein touted the Cognivue as the 1st such device approved by the FDA. The device is designed to allow practitioners to monitor current brain health and […]